Literature DB >> 10805828

Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection.

J A Kovacs1, H Masur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805828     DOI: 10.1056/NEJM200005113421907

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease.

Authors:  Peter S Arno; Marc N Gourevitch; Ernest Drucker; Jing Fang; Clara Goldberg; Margaret Memmott; Karen Bonuck; Nandini Deb; Ellie Schoenbaum
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

3.  Immune Reconstitution Strategies in HIV.

Authors:  Matthew R. Leibowitz; Ronald T. Mitsuyasu
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

4.  Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies.

Authors:  Wee J Chng; Guat B Tan; Ponnudurai Kuperan
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 5.  The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia.

Authors:  R J Boyton; D M Mitchell; O M Kon
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 6.  Novel paradigms for drug discovery: computational multitarget screening.

Authors:  Ekachai Jenwitheesuk; Jeremy A Horst; Kasey L Rivas; Wesley C Van Voorhis; Ram Samudrala
Journal:  Trends Pharmacol Sci       Date:  2008-01-10       Impact factor: 14.819

7.  Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research.

Authors:  Homer L Twigg; Ronald Crystal; Judith Currier; Paul Ridker; Nancy Berliner; Hans-Peter Kiem; George Rutherford; Shimian Zou; Simone Glynn; Renee Wong; Emmanuel Peprah; Michael Engelgau; Tony Creazzo; Sandra Colombini-Hatch; Elisabet Caler
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

8.  Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients.

Authors:  G Piccinini; G Comolli; E Genini; D Lilleri; R Gulminetti; R Maccario; M G Revello; G Gerna
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

9.  Hospitalization risk following initiation of highly active antiretroviral therapy.

Authors:  S A Berry; Y C Manabe; R D Moore; K A Gebo
Journal:  HIV Med       Date:  2009-12-08       Impact factor: 3.180

10.  Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis.

Authors:  Richard Ssekitoleko; Moses R Kamya; Arthur L Reingold
Journal:  Future Virol       Date:  2013-09       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.